ISREUR
Perspective Therapeutics, Inc.
Clinical-stage radiopharmaceutical company developing targeted alpha-particle therapies (theranostics) for cancer using Lead-212.
CUSIP: 46489V104HealthcareUS1 holder
Total Value
$3.55M
Total Shares
1.00M
Net Share Change
+1.00M
Activity
1 buying
Investor
Value
Shares
Weight
Change
